JUNIPER PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Four
JUNIPER PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $192.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2017-11-02
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $192.00K.
- 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $186.00K.
- 2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $179.00K.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $176.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Four |
|---|---|
| 2017-09-30 | $192.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $186.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $179.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $176.00K 10-K · filed 2017-03-07 |
| 2016-09-30 | $252.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $260.00K 10-Q/A · filed 2016-11-14 |
| 2016-03-31 | $279.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $287.00K 10-K/A · filed 2016-11-14 |
| 2015-09-30 | $325.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $337.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $318.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $333.00K 10-K · filed 2015-03-18 |
| 2014-09-30 | $380.00K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $398.00K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $389.00K 10-Q · filed 2014-05-02 |
| 2013-12-31 | $385.59K 10-K · filed 2014-03-05 |